Medicines and Medical Devices Bill
Debate between Lord Kakkar and Lord Russell of Liverpool
Committee stage
&
Committee: 2nd sitting (Hansard)
&
Committee: 2nd sitting (Hansard): House of Lords
Monday 26th October 2020
Read Full debate Medicines and Medical Devices Act 2021 View all Medicines and Medical Devices Act 2021 Debates Read Hansard Text Read Debate Ministerial Extracts Amendment Paper: HL Bill 116-III(Rev) Revised third marshalled list for Grand Committee - (26 Oct 2020)
Monday 26th October 2020
(4 years, 2 months ago)
Grand CommitteeRead Full debate Medicines and Medical Devices Act 2021 View all Medicines and Medical Devices Act 2021 Debates Read Hansard Text Read Debate Ministerial Extracts Amendment Paper: HL Bill 116-III(Rev) Revised third marshalled list for Grand Committee - (26 Oct 2020)
The Deputy Chairman of Committees (Lord Russell of Liverpool) (CB)
We seem to have lost the noble Lord, Lord Kakkar.
The Deputy Chairman of Committees (Lord Russell of Liverpool) (CB)
Lord Kakkar, please keep going. We lost you for a minute.
Lord Kakkar (CB) [V]
Is the Minister able to indicate why there might be anxiety about giving priority to safety? Is it because methodology by way of clinical trials evaluation is not sufficiently well developed to make that a statutory principle for the availability of medicinal products or medical devices? Is it that there might be some basis for legal challenge that would make this ill-advised? If not, it appears that putting safety at the forefront is in the interests of patients, our healthcare system, clinicians and the standing of our country as a place to lead in the development of the life sciences.